Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2
Coronavirus disease 2019 (COVID-19) was caused by a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 utilizes human angiotensin converting enzyme 2 (hACE2) as the cellular receptor of its spike glycoprotein (SP) to gain entry into cells. Consequently, we focu...
Saved in:
Main Authors: | Xi Chen (Author), Ziyuan Wang (Author), Jing Wang (Author), Yifan Yao (Author), Qian Wang (Author), Jiahao Huang (Author), Xianping Xiang (Author), Yifan Zhou (Author), Yintong Xue (Author), Yan Li (Author), Xiang Gao (Author), Lijun Wang (Author), Ming Chu (Author), Yuedan Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2
by: Arun Bahadur Gurung, et al.
Published: (2021) -
Study of Potential Blocking Peptides Targeting the SARS-CoV-2 RBD/hACE2 Interaction
by: Sara M. Villada-Troncoso, et al.
Published: (2024) -
ACE2 : S1 RBD Interaction-Targeted Peptides and Small Molecules as Potential COVID-19 Therapeutics
by: Lennox Chitsike, et al.
Published: (2021) -
Rapid screening of SARS-CoV-2 inhibitors via ratiometric fluorescence of RBD-ACE2 complexes in living cells by competitive binding
by: Lu Miao, et al.
Published: (2022) -
1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection
by: Rui Hong Chen, et al.
Published: (2021)